Inari Medical to buy limb-saving device maker LimFlow for up to $415M
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Inari Medical has agreed to acquire
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Inari Medical has agreed to acquire
More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Competition in the fast-growing pulsed field ablation